Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Belimumab Combination Therapy in PR3 ANCA-associated Vasculitis
NCT03967925Phase 2Unknown
- Start
- Feb 2019
- Primary completion
- Apr 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in Antineutrophil cytoplasmic antibody-associated vasculitis (AAV), granulomatosis with polyangiitis (GPA). Status: unknown.
02
Drugs
belimumab
03
Conditions
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on NCT03967925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967925.